Baur, R; Gertsch, J; Sigel, E (2012). The cannabinoid CB1 receptor antagonists rimonabant (SR141716) and AM251 directly potentiate GABA(A) receptors. British journal of pharmacology, 165(8), pp. 2479-84. Oxford: Wiley-Blackwell 10.1111/j.1476-5381.2011.01405.x
Full text not available from this repository. (Request a copy)Rimonabant (SR141716) and the structurally related AM251 are widely used in pharmacological experiments as selective cannabinoid receptor CB(1) antagonists / inverse agonists. Concentrations of 0.5-10 µM are usually applied in in vitro experiments. We intended to show that these drugs did not act at GABA(A) receptors but found a significant positive allosteric modulation instead.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Biochemistry and Molecular Medicine |
UniBE Contributor: |
Baur, Roland, Gertsch, Jürg, Sigel, Erwin |
ISSN: |
0007-1188 |
Publisher: |
Wiley-Blackwell |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 14:37 |
Last Modified: |
05 Dec 2022 14:11 |
Publisher DOI: |
10.1111/j.1476-5381.2011.01405.x |
PubMed ID: |
21470203 |
Web of Science ID: |
000301925200008 |
URI: |
https://boris.unibe.ch/id/eprint/15043 (FactScience: 222197) |
Actions (login required)
 |
Edit item |